What does PHARMADEVILLE do?

PHARMADEVILLE is a pharmacy in Bernissart. Private Limited, started on 19 July 2000, 1 establishment.

What is the address of PHARMADEVILLE?

The registered office of PHARMADEVILLE is located at Rue de Ville(POM) 7, 7322 Bernissart.

Is PHARMADEVILLE still active?

Yes. According to the CBE (30 October 2026) PHARMADEVILLE is active, legal situation “Normale toestand”, started on 19 July 2000.

Is PHARMADEVILLE registered on Peppol?

Yes, PHARMADEVILLE is registered on the Peppol network with ID 0208:0472445725.

What is the enterprise number of PHARMADEVILLE?

The enterprise number of PHARMADEVILLE is BE0472445725.

When was PHARMADEVILLE founded?

PHARMADEVILLE was founded on 19 July 2000.

Who are the directors of PHARMADEVILLE?

According to the 2025 annual accounts, the directors of PHARMADEVILLE are: JEAN-CHRISTOPHE CRASSET.

Is PHARMADEVILLE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 July 2000; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMADEVILLE make in 2025?

PHARMADEVILLE recorded a loss after taxes of € 17,348 in financial year 2025.

What is the revenue of PHARMADEVILLE?

As a small company, PHARMADEVILLE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 42,581.

Does PHARMADEVILLE have a website?

Yes, PHARMADEVILLE has a website at pharmacie-crasset.be.

PHARMADEVILLE (Private Limited) - Bernissart

Dossier PHARMADEVILLE, printed on 30 October 2026 from databakkes.be/en/0472445725/pharmadeville. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 39 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMADEVILLE from Bernissart, company number BE0472445725, closed financial year 2025 with a result of € -17,348 after tax. For that financial year PHARMADEVILLE recorded a gross margin of € 42,581 and equity of € 47,332. Compared with financial year 2024, the result moved from € 10,784 to € -17,348. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Healthy

€ 47,332

▼ 41% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -17,348

▼ still € 10,784 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 8,651

▼ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 28,740.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 32,323

▲ 28% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 21,098

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 120,527

▲ 29% vs 2024

€ 30,389 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 67,900

▲ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 7,174

▲ 141% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 92,342 Gross margin 2022: € 92,342 First fiscal year in the series	€ 61,344 Gross margin 2023: € 61,344 ▼ 34% vs 2022 (€ 92,342) Unfavourable step	€ 53,395 Gross margin 2024: € 53,395 ▼ 13% vs 2023 (€ 61,344) Unfavourable step	€ 42,581 Gross margin 2025: € 42,581 ▼ 20% vs 2024 (€ 53,395) Unfavourable step	▼ 20%
Profit after taxes	€ 8,451 Profit after taxes 2022: € 8,451 First fiscal year in the series	€ -19,536 Profit after taxes 2023: € -19,536 ▼ € 27,986 vs 2022 (€ 8,451) Unfavourable step	€ 10,784 Profit after taxes 2024: € 10,784 ▲ € 30,320 vs 2023 (€ -19,536) Favourable step	€ -17,348 Profit after taxes 2025: € -17,348 ▼ € 28,133 vs 2024 (€ 10,784) Unfavourable step	▼ € 28,133
Equity	€ 88,432 Equity 2022: € 88,432 First fiscal year in the series	€ 68,896 Equity 2023: € 68,896 ▼ 22% vs 2022 (€ 88,432) Unfavourable step	€ 79,681 Equity 2024: € 79,681 ▲ 16% vs 2023 (€ 68,896) Favourable step	€ 47,332 Equity 2025: € 47,332 ▼ 41% vs 2024 (€ 79,681) Unfavourable step	▼ 41%
Total debts	€ 233,111 Total debts 2022: € 233,111 First fiscal year in the series	€ 188,388 Total debts 2023: € 188,388 ▼ 19% vs 2022 (€ 233,111) Favourable step	€ 159,352 Total debts 2024: € 159,352 ▼ 15% vs 2023 (€ 188,388) Favourable step	€ 210,601 Total debts 2025: € 210,601 ▲ 32% vs 2024 (€ 159,352) Unfavourable step	▲ 32%
Cash	€ 20,707 Cash 2022: € 20,707 First fiscal year in the series	€ 11,941 Cash 2023: € 11,941 ▼ 42% vs 2022 (€ 20,707) Unfavourable step	€ 12,853 Cash 2024: € 12,853 ▲ 8% vs 2023 (€ 11,941) Favourable step	€ 8,651 Cash 2025: € 8,651 ▼ 33% vs 2024 (€ 12,853) Unfavourable step	▼ 33%
Land & buildings	€ 105,358 Land & buildings 2022: € 105,358 First fiscal year in the series	€ 97,922 Land & buildings 2023: € 97,922 ▼ 7% vs 2022 (€ 105,358) Unchanged	€ 90,486 Land & buildings 2024: € 90,486 ▼ 8% vs 2023 (€ 97,922) Unchanged	€ 83,050 Land & buildings 2025: € 83,050 ▼ 8% vs 2024 (€ 90,486) Unchanged	▼ 8%
Retained profit	€ 69,840 Retained profit 2022: € 69,840 First fiscal year in the series	€ 50,304 Retained profit 2023: € 50,304 ▼ 28% vs 2022 (€ 69,840) Unfavourable step	€ 61,089 Retained profit 2024: € 61,089 ▲ 21% vs 2023 (€ 50,304) Favourable step	€ 28,740 Retained profit 2025: € 28,740 ▼ 53% vs 2024 (€ 61,089) Unfavourable step	▼ 53%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 15,000 Dividend 2025: € 15,000 Unchanged (€ 0) Unchanged
Bank debt	€ 165,498 Bank debt 2022: € 165,498 First fiscal year in the series	€ 119,371 Bank debt 2023: € 119,371 ▼ 28% vs 2022 (€ 165,498) Favourable step	€ 93,336 Bank debt 2024: € 93,336 ▼ 22% vs 2023 (€ 119,371) Favourable step	€ 120,527 Bank debt 2025: € 120,527 ▲ 29% vs 2024 (€ 93,336) Unfavourable step	▲ 29%
Balance sheet total	€ 321,543 Balance sheet total 2022: € 321,543 First fiscal year in the series	€ 257,284 Balance sheet total 2023: € 257,284 ▼ 20% vs 2022 (€ 321,543) Unchanged	€ 239,033 Balance sheet total 2024: € 239,033 ▼ 7% vs 2023 (€ 257,284) Unchanged	€ 257,934 Balance sheet total 2025: € 257,934 ▲ 8% vs 2024 (€ 239,033) Unchanged	▲ 8%

Key figures of PHARMADEVILLE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMADEVILLE?

What happened at PHARMADEVILLE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: loss of € 17,348 (▼ € 28,133 vs 2024). Source: NBB ↗
2021 JEAN-CHRISTOPHE CRASSET became a director. NBB
Jul 31, 2000 New establishment in Bernissart. KBO
Jul 19, 2000 Start of the company according to the CBE. KBO

In short

From € 8,451 profit in 2022 to € 17,348 loss in 2025.

Paid € 3,339 in corporate taxes since 2022.

Best year ever: 2024, with € 10,784 profit.

Paid out € 15,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

JEAN-CHRISTOPHE CRASSET

PHARMADEVILLE

Behind PHARMADEVILLE is JEAN-CHRISTOPHE CRASSET.

Directors

According to the 2025 annual accounts

JEAN-CHRISTOPHE CRASSET

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Ville(POM) 7

7322 Bernissart

2.100.904.687

Rue de Ville(POM) 5 7

7322 Bernissart

Active since 31 July 2000

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmacie-crasset.be

About

Technologies

ASP.NETApacheElementorFont AwesomeGoogle FontsGoogle MapsPHPPWASwiperWooCommerceWordPressYoast SEOjQuery

Hosting & Email

Email provider

Self-hosted

Hosting

HETZNER-AS, DE

Website info

HTTPS Ja

Languages FR

Features

Webshop Blog Newsletter Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number: 0472.445.725
VAT number: BE 0472.445.725
Registered office: Rue de Ville(POM) 7, 7322 Bernissart
Names & denominations: PHARMADEVILLE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 July 2000
Peppol: Active · Active since 21 Jan 2025
Contact: pharmacie-crasset.be
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗